The EQIPD project was presented at the PreNeuroscience 2018 Seminar and Networking event that took place on 2 November 2018 in
conjunction with the Society for Neuroscience’s (SfN) annual meeting in San Diego, California, USA, to create awareness in the USA as well – Download our 2nd newsletter to see more updates and news!
The first Newsletter by the EQIPD consortium can be found HERE.
The Research Transparency Tool was developed by the EQIPD Consortium Taskforce and implemented online with support from a SBIR award from the NIH: https://public-funding-tool.paasp.net/survey The tool creates a “snapshot” of the environment in which research is conducted and is meant to help funders and applicants align on relevant quality expectations. More information in the EQIPD…
In the newest edition of the newsletter, find out more about the highlights of the EQIPD General Assembly meeting, the new project collaborations, CAMARADES winning the BNA’s ‘Credibility Prize’ and details on the 34th ECNP congress. Read the Newsletter here.
Our book on quality in preclinical research, including many articles from authors within the EQIPD consortium, has just been published: Bespalov A, Michel MC, Steckler T (eds) Handbook of Experimental Pharmacology – Good Research Practice in Non-Clinical Pharmacology and Biomedicine, Springer Open, Cham, Switzerland. ISBN 978-3-030-33655-4, eBook ISBN 978-3-030-33656-1 (2020). Access the book HERE.
The EQIPD Quality System is the result of a collaborative effort between several people and organizations, yet cannot specifically address all potential scenarios under which research rigor measures are needed and will be implemented. The foundation laid by EQIPD is formulated in the “core requirements” (see link below) and we welcome further efforts to support…
The “Guarantors of EQIPD” officially announced their launch with a public press release. The society is registered since December 2021 and became fully operational now. Read the press release here.